AAAAAA
Results: 1-25/77
Authors:
GASSEN M
GROSS A
YOUDIM MBH
Citation: M. Gassen et al., APOMORPHINE ENANTIOMERS PROTECT CULTURED PHEOCHROMOCYTOMA (PC12) CELLS FROM OXIDATIVE STRESS-INDUCED BY H2O2 AND 6-HYDROXYDOPAMINE, Movement disorders, 13(4), 1998, pp. 661-667
Authors:
GASSEN M
GROSS A
YOUDIM MBH
Citation: M. Gassen et al., APOMORPHINE ENANTIOMERS PROTECT CULTURED PHEOCHROMOCYTOMA (PC12) CELLS FROM OXIDATIVE STRESS-INDUCED BY H2O2 AND 6-HYDROXYDOPAMINE, Movement disorders, 13(2), 1998, pp. 242-248
Authors:
FINBERG JPM
YOUDIM MBH
RIEDERER P
TIPTON KF
Citation: Jpm. Finberg et al., MAO - THE MOTHER OF ALL AMINE OXIDASES - PREFACE, Journal of neural transmission. Supplementum, (52), 1998, pp. 3-4
Authors:
HOCHERMAN S
LEVIN G
GILADI N
YOUDIM MBH
Citation: S. Hocherman et al., DEPRENYL MONOTHERAPY IMPROVES VISUO-MOTOR CONTROL IN EARLY PARKINSONISM, Journal of neural transmission. Supplementum, (52), 1998, pp. 63-69
Authors:
GOTZ ME
BREITHAUPT W
SAUTTER J
KUPSCH A
SCHWARZ J
OERTEL WH
YOUDIM MBH
RIEDERER P
GERLACH M
Citation: Me. Gotz et al., CHRONIC TVP-1012 (RASAGILINE) DOSE - ACTIVITY RESPONSE OF MONOAMINE OXIDASE-A AND OXIDASE-B IN THE BRAIN OF THE COMMON MARMOSET, Journal of neural transmission. Supplementum, (52), 1998, pp. 271-278
Authors:
GLINKA Y
TIPTON KF
YOUDIM MBH
Citation: Y. Glinka et al., MECHANISM OF INHIBITION OF MITOCHONDRIAL RESPIRATORY COMPLEX-I BY 6-HYDROXYDOPAMINE AND ITS PREVENTION BY DESFERRIOXAMINE, European journal of pharmacology, 351(1), 1998, pp. 121-129
Authors:
GASSEN M
PERGANDE G
YOUDIM MBH
Citation: M. Gassen et al., ANTIOXIDANT PROPERTIES OF THE TRIAMINOPYRIDINE, FLUPIRTINE, Biochemical pharmacology, 56(10), 1998, pp. 1323-1329
Authors:
BICK T
AMIT T
MAOR G
YOUDIM MBH
GREEN J
Citation: T. Bick et al., INDUCTION OF DIFFERENTIATION IN OSTEOBLAST-LIKE CELLS BY DIMETHYLSULFOXIDE (DMSO), Journal of the American Society of Nephrology, 8, 1997, pp. 1844-1844
Authors:
DICK T
AMIT T
MAOR CI
SEGEV Y
PHILLIP M
YOUDIM MBH
GREEN J
Citation: T. Dick et al., DIFFERENTIAL MITOGENIC EFFECTS OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) AND IGF-1 BINDING IN OSTEOBLAST-LIKE CELLS, Journal of the American Society of Nephrology, 8, 1997, pp. 2009-2009
Authors:
GASSEN M
YOUDIM MBH
Citation: M. Gassen et Mbh. Youdim, THE POTENTIAL ROLE OF IRON CHELATORS IN THE TREATMENT OF PARKINSONS-DISEASE AND RELATED NEUROLOGICAL DISORDERS, Pharmacology & toxicology, 80(4), 1997, pp. 159-166
Authors:
GERLACH M
DOUBLE K
RIEDERER P
HIRSCH E
JELLINGER K
JENNER P
TRAUTWEIN A
YOUDIM MBH
Citation: M. Gerlach et al., IRON IN THE PARKINSONIAN SUBSTANTIA-NIGRA, Movement disorders, 12(2), 1997, pp. 258-259
Authors:
YOUDIM MBH
GASSEN M
GLINKA Y
JELLINGER K
LINERT W
Citation: Mbh. Youdim et al., MECHANISM OF 6-HYDROXYDOPAMINE INDUCED NEUROTOXICITY OF NIGRA-STRIATAL DOPAMINE NEURONS, Neuroscience letters, 1997, pp. 53-54
Authors:
YOUDIM MBH
BENSHACHAR D
ESHEL G
Citation: Mbh. Youdim et al., NEUROPROTECTION BY DESFERRIOXAMINE AND LIPOIC ACID AGAINST 6-HYDROXYDOPAMINE INDUCED DOPAMINERGIC NEUROTOXICITY, Neuroscience letters, 1997, pp. 54-54
Authors:
GLINKA Y
GASSEN M
YOUDIM MBH
Citation: Y. Glinka et al., MECHANISM OF 6-HYDROXYDOPAMINE NEUROTOXICITY, Journal of neural transmission. Supplementum, (50), 1997, pp. 55-66
Authors:
YOUDIM MBH
RIEDERER P
Citation: Mbh. Youdim et P. Riederer, UNDERSTANDING PARKINSONS-DISEASE, Scientific American, 276(1), 1997, pp. 52-59
Authors:
AMIT T
BERGMAN T
DASTOT F
YOUDIM MBH
AMSELEM S
HOCHBERG Z
Citation: T. Amit et al., A MEMBRANE-FIXED, TRUNCATED ISOFORM OF THE HUMAN GROWTH-HORMONE RECEPTOR, The Journal of clinical endocrinology and metabolism, 82(11), 1997, pp. 3813-3817
Authors:
BICK T
AMIT T
YOUDIM MBH
GREEN J
Citation: T. Bick et al., REGULATION OF NA-DEPENDENT PI TRANSPORT (NAPIT) BY INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) AND PARATHYROID-HORMONE (PTH) IN RAT OSTEOBLAST-LIKE CELLS(), Journal of the American Society of Nephrology, 7(9), 1996, pp. 2758-2758
Authors:
AMIT T
BICK T
YOUDIM MBH
GREEN J
Citation: T. Amit et al., DIFFERENTIAL REGULATION OF GROWTH-HORMONE RECEPTOR (GHR) IN RAT OSTEOBLAST-LIKE CELLS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2819-2819
Authors:
LINERT W
HERLINGER E
JAMESON RF
KIENZL E
JELLINGER K
YOUDIM MBH
Citation: W. Linert et al., DOPAMINE, 6-HYDROXYDOPAMINE, IRON, AND DIOXYGEN - THEIR MUTUAL INTERACTIONS AND POSSIBLE IMPLICATION IN THE DEVELOPMENT OF PARKINSONS-DISEASE, Biochimica et biophysica acta. Molecular basis of disease, 1316(3), 1996, pp. 160-168
Authors:
GERLACH M
DESSER H
YOUDIM MBH
RIEDERER P
Citation: M. Gerlach et al., NEW HORIZONS IN MOLECULAR MECHANISMS UNDERLYING PARKINSONS-DISEASE AND IN OUR UNDERSTANDING OF THE NEUROPROTECTIVE EFFECTS OF SELEGILINE, Journal of neural transmission. Supplementum, (48), 1996, pp. 7-21
Authors:
FINBERG JPM
LAMENSDORF I
COMMISSIONG JW
YOUDIM MBH
Citation: Jpm. Finberg et al., PHARMACOLOGY AND NEUROPROTECTIVE PROPERTIES OF RASAGILINE, Journal of neural transmission. Supplementum, (48), 1996, pp. 95-101
Authors:
YOUDIM MBH
GLINKA Y
Citation: Mbh. Youdim et Y. Glinka, IRON-DEPENDENT MECHANISMS OF DOPAMINERGIC TOXICITY OF 6-HYDROXYDOPAMINE, Biogenic amines, 12(2), 1996, pp. 181-190
Authors:
GERLACH M
YOUDIM MBH
RIEDERER P
Citation: M. Gerlach et al., PHARMACOLOGY OF SELEGILINE, Neurology, 47(6), 1996, pp. 137-145
Authors:
LAMENSDORF I
YOUDIM MBH
FINBERG JPM
Citation: I. Lamensdorf et al., EFFECT OF LONG-TERM TREATMENT WITH SELECTIVE MONOAMINE-OXIDASE-A AND MONOAMINE-OXIDASE-B INHIBITORS ON DOPAMINE RELEASE FROM RAT STRIATUM IN-VIVO, Journal of neurochemistry, 67(4), 1996, pp. 1532-1539
Authors:
GLINKA Y
TIPTON KF
YOUDIM MBH
Citation: Y. Glinka et al., NATURE OF INHIBITION OF MITOCHONDRIAL RESPIRATORY COMPLEX-I BY 6-HYDROXYDOPAMINE, Journal of neurochemistry, 66(5), 1996, pp. 2004-2010